Scinovex
Subscribe
A

Arndt Vogel

University Health Network (CA)ORCID 0000-0003-0560-5538
h-index
83
Publications
768
Citations
39.3K
i10-index
313
Impact (2-yr)
13.14
Citations per year
Research Areas
Hepatocellular Carcinoma Treatment and PrognosisCholangiocarcinoma and Gallbladder Cancer StudiesColorectal Cancer Treatments and StudiesPancreatic and Hepatic Oncology ResearchLiver Disease Diagnosis and Treatment
Affiliations
Ontario Institute for Cancer Research
CA · 2025–2025
Goethe University Frankfurt
DE · 2017–2017
Leibniz University Hannover
DE · 2024–2024
Oslo University Hospital
NO · 2024–2024
University of Minnesota
US · 2021–2021
Nanjing University of Chinese Medicine
CN · 2023–2023
University Health Network
CA · 2023–2026
Humanitas University
IT · 2023–2023

Top Publications

Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial
The Lancet20185,305 citations
Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial
The Lancet Oncology20182,498 citations
Pemigatinib for previously treated, locally advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 study
The Lancet Oncology20201,533 citations
Gastric cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
Annals of Oncology20221,260 citations
Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Annals of Oncology20181,047 citationsFirst authorCorresponding
Low-power VLSI design for next-generation wireless communication systems
International Journal of Research in Circuits Devices and Systems20250 citations
AI-enhanced edge devices, real-time signal processing, Internet of Things (IoT), latency reduction, bandwidth efficiency
International Journal of Electronic Devices and Networking20250 citations
Arndt Vogel · Scinovex